5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | SELL | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.75▼ | 4.75▼ | 4.75▲ | 4.67▲ | 4.76▼ |
MA10 | 4.75▼ | 4.75▼ | 4.75▼ | 4.75▼ | 4.47▲ |
MA20 | 4.75▲ | 4.75▼ | 4.73▲ | 4.79▼ | 4.29▲ |
MA50 | 4.75▼ | 4.69▲ | 4.70▲ | 4.43▲ | 3.94▲ |
MA100 | 4.75▼ | 4.71▲ | 4.80▼ | 4.26▲ | 3.48▲ |
MA200 | 4.73▲ | 4.80▼ | 4.69▲ | 4.02▲ | 3.35▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | -0.004▼ | 0.003▲ | -0.040▼ | 0.055▲ |
RSI | 50.190▲ | 53.958▲ | 56.283▲ | 56.370▲ | 65.520▲ |
STOCH | 61.111 | 56.012 | 33.742 | 19.170▼ | 85.225▲ |
WILL %R | -33.333 | -60.000 | -71.429 | -61.224 | -24.590▲ |
CCI | 78.788 | -31.658 | -52.716 | -29.330 | 79.172 |
CDL | $SAN Doji Candlestick Pattern Detected | Set Alert |
Saturday, April 20, 2024 03:01 AM
ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments ...
|
Friday, April 19, 2024 04:15 PM
The awards were granted under Iovance’s 2021 Inducement Plan, which was adopted on September 22, 2021 and amended on January 12, 2022, March 13, 2023, and February 26, 2024 and provides for the ...
|
Friday, April 19, 2024 04:11 PM
The Letter has no immediate effect on the listing or trading of the Company’s American Depositary Shares representing ordinary shares (“ADSs”), which will continue to be listed on Nasdaq during this ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
19/04/24 | 4.75 | 4.78 | 4.73 | 4.75 | 2,958,477 |
18/04/24 | 4.75 | 4.80 | 4.73 | 4.75 | 2,964,859 |
17/04/24 | 4.69 | 4.705 | 4.64 | 4.66 | 3,101,485 |
16/04/24 | 4.64 | 4.645 | 4.56 | 4.57 | 6,259,020 |
15/04/24 | 4.73 | 4.75 | 4.635 | 4.64 | 2,470,083 |
12/04/24 | 4.70 | 4.71 | 4.64 | 4.65 | 2,687,125 |
11/04/24 | 4.76 | 4.78 | 4.67 | 4.76 | 3,270,317 |
10/04/24 | 4.85 | 4.905 | 4.82 | 4.87 | 2,928,006 |
09/04/24 | 4.98 | 4.9975 | 4.89 | 4.92 | 2,223,726 |
08/04/24 | 4.97 | 5.00 | 4.95 | 4.98 | 4,920,588 |
|
|
||||
|
|
||||
|
|